Tatva Chintan Pharma Chem Ltd. is proposing an Initial Public Offering (IPO) on the NSE & BSE platform under the Mainboard category.
Subscription opens 16 Jul 2021, closes 20 Jul 2021. Listing expected 28 Jul 2021. Apply via ASBA or UPI.
Tatva Chintan Pharma Chem Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 13 | ₹14,079 |
| Retail (Max) | 13 | 169 | ₹183,027 |
| sNII (Min) | 15 | 195 | ₹211,185 |
| bNII (Min) | 72 | 936 | ₹1,013,688 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |